SCHEMBL6803095

SCHEMBL6803095

CSCC[C@H](NC(=O)OC(C)(C)C)C(=O)N(C)[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
CA2 P00918 1/20 0.46
FNTA P49354 2/20 0.41
FNTB P49356 2/20 0.41
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
CCKBR P32239 2/20 0.38
POLB P06746 1/20 0.38
KLK7 P49862 1/20 0.37
EPHX2 P34913 1/20 0.37
TACR3 P29371 1/20 0.37
REN P00797 1/20 0.37
KLK5 Q9Y337 1/20 0.36
ITGA4 P13612 1/20 0.36
ITGB7 P26010 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6799986 0.89 PPARG (0.49) PPARGPPARACTSSCTSKCCKBR
SCHEMBL6919468 0.87 PPARG (0.50) PPARGPPARACTSSCTSKCCKBR
SCHEMBL6796934 0.86 PPARA (0.49) PPARGPPARACA2CTSSCTSK
SCHEMBL6802603 0.86 PPARG (0.47) PPARGPPARAREN
SCHEMBL6807847 0.86 CTSS (0.48) PPARGPPARACTSSCTSKCCKBR
SCHEMBL6803652 0.84 PTPRB (0.48) CA2
SCHEMBL6800420 0.83 PPARG (0.44) PPARGPPARACA2KLK5MMP1
SCHEMBL500111 0.79 PPARG (0.58) PPARGPPARACA2CTSSCTSK
SCHEMBL4714186 0.79 PPARG (0.58) PPARGPPARACA2CTSSCTSK
SCHEMBL500110 0.79 PPARG (0.58) PPARGPPARACA2CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004074238-A1 PHENETHYLAMINO SULFAMIC ACIDS THE PROCTER & GAMBLE COMPANY (US) 2004-09-02 WO disclosed
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167183-A1 Phenethylamino sulfamic acids PTPRM, PTPRS, PTPRE PPARG 1041/4885PPARA 1031/4885CA2 1472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.